Addressing engineering challenges with bispecific and immunocytokine drugs
23 Jun 2025
Formats & Scaffolds
- How to solve the challenges of small therapeutic windows for cytokine treatment
- Manufacturing and stability concerns with chimeric protein drugs
- How to select optimal functional units and linkers
- Selecting the right assays to predict in vivo efficacy
Industry Expert
